Kalohexis Appoints Xuan Hui, B.Med., M.S., Ph.D., as Director of Corporate Strategy

/PRNewswire/ -- Kalohexis, Inc., a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care...